Genetically Modified Pertussis Vaccine Produces Lasting Response Genetically Modified Pertussis Vaccine Produces Lasting Response

Monovalent and combined acellular pertussis vaccines made with genetically inactivated toxin produce a stronger and more sustained antibody response than those containing chemically inactivated toxin, a new phase 2/3 trial shows.Reuters Health Information

Source: Medscape Today Headlines - October 10, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news